Evidence map›Paper›PMID 22370873›Full record

ReviewCerebellum (London, England)2012

Consensus paper: pathological role of the cerebellum in autism.

S Hossein Fatemi, Kimberly A Aldinger, Paul Ashwood, Margaret L Bauman, Charles D Blaha, Gene J Blatt, Abha Chauhan, Ved Chauhan, Stephen R Dager, Price E Dickson and 13 more

Registry-linked trialOpen access · bronzeAbstract readReviewConsensus Statement
In one paragraph

Review in Cerebellum (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05781412 (Modulation of the Activity in the Cerebellum With Transcranial Direct Current Stimulation in Autistic Participants), which is not on this map. Cited by 383 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
383citing papers in PubMed, 5 pooled it
23.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05781412 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Modulation of the Activity in the Cerebellum With Transcranial Direct Current Stimulation in Autistic Participants

TypeinterventionalSponsorBeatriz CatoiraRan2022 to 2024Enrolled100ConditionsAutism Spectrum DisorderArmstDCS
3 · Its place in the literature

Who cites it

383 citing papers in PubMed, 5 syntheses or guidelines pooled it, 726 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Oxytocin induces long-lasting adaptations within amygdala circuitry in autism: a treatment-mechanism study with randomized placebo-controlled design.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

323 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 15 institutions in 3 countries.

S Hossein FatemiUniversity of Minnesota Medical School, 420 Delaware St. SE, Minneapolis, MN 55455, USA. fatem002@umn.edu
Kimberly A Aldinger
Paul Ashwood
Margaret L Bauman
Charles D Blaha
Gene J Blatt
Abha Chauhan
Ved Chauhan
Stephen R Dager
Price E Dickson
Annette M Estes
Dan Goldowitz
Detlef H Heck
Thomas L Kemper
Bryan H King
Loren A Martin
Kathleen J Millen
Guy Mittleman
Matthew W Mosconi
Antonio M Persico
John A Sweeney
Sara J Webb
John P Welsh
Seattle University · USUniversity of Memphis · USBoston University · USNew York State Office for People With Developmental Disabilities · USThe University of Texas Southwestern Medical Center · USUniversity of Washington · USAzusa Pacific University · USFondazione Santa Lucia · ITHarvard University · USNeuroDevelopment Center · USSeattle Children's Hospital · USUniversity of British Columbia · CAUniversity of Minnesota · USUniversity of Southern California · USUniversity of Tennessee Health Science Center · US

Funding

Cellular and molecular mechanisms governing cortical surface area overgrowth in iPSC-derived neural cells from longitudinally characterized individuals with autismR01HD055741 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph Piven · 2007 to 2026
$52.6M
Southern California Clinical and Translational Science InstituteUL1TR000130 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BUCHANAN, THOMAS A · 2012 to 2015
$36.0M
UW Autism Center of ExcellenceP50HD055782 · NICHD · UNIVERSITY OF WASHINGTON · PI ABBOTT, ROBERT D · 2007 to 2011
$11.0M
TRANS STUDIES OF COGNITIVE,AFFECTIVE/NEUROCHEMICAL PROCESSES UNDERLYING INSISTENCP50HD055751 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI COOK, EDWIN H · 2007 to 2011
$9.5M
CENTRAL RHYTHMOGENESIS AND BEHAVIORR01NS031224 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI WELSH, JOHN P · 1993 to 2019
$7.4M
PRECURSORS TO LANGUAGE IN AUTISMP01HD035465 · NICHD · UNIVERSITY OF WASHINGTON · PI SCHELLENBERG, GERARD DAVID · 1997 to 2001
$3.5M
Olivocerebellar Circuitry in AutismR01HD039459 · NICHD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BLATT, GENE J · 2002 to 2010
$2.4M
Dorsal midline patterning in the vertebrate CNSR01NS072441 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI MILLEN, KATHLEEN JOYCE · 2010 to 2014
$2.3M
Southern California Clinical and Translational Science InstituteKL2TR000131 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BUCHANAN, THOMAS A · 2012 to 2015
$2.1M
NEUROBIOLOGIC STUDIES OF THE LIMBIC SYSTEM IN AUTISMR01NS038975 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAUMAN, MARGARET L · 2000 to 2004
$1.6M
Cerebellar Modulation of Frontal Cortical FunctionR01NS063009 · NINDS · UNIVERSITY OF MEMPHIS · PI BLAHA, CHARLES, GOLDOWITZ, DANIEL · 2009 to 2013
$1.6M
GABAergic Dysfunction in AutismR01HD052074 · NICHD · UNIVERSITY OF MINNESOTA · PI FATEMI, SEYYED HOSSEIN · 2007 to 2011
$1.5M
Autism Speaks AS3587NCATS NIH HHS KL2 TR000131NCATS NIH HHS UL1 TR000130NICHD NIH HHS 3R01HD05207403-S1NICHD NIH HHS 5R01HD039459-06NICHD NIH HHS 5R01HD052074-05NICHD NIH HHS HD35465NICHD NIH HHS P01 HD035465NICHD NIH HHS P50 HD055751NICHD NIH HHS P50HD055751NICHD NIH HHS P50 HD055782NICHD NIH HHS P50-HD055782NICHD NIH HHS R01 HD039459NICHD NIH HHS R01 HD052074NICHD NIH HHS R01 HD05571NICHD NIH HHS R01-HD055741NICHD NIH HHS R01 HD065283NICHD NIH HHS R01-HD065283NICHD NIH HHS R21 HD065269NICHD NIH HHS R21HD065269NIMH NIH HHS 1K23MH092696NIMH NIH HHS K23 MH092696NINDS NIH HHS NS38975-05NINDS NIH HHS R01 NS031224NINDS NIH HHS R01 NS038975NINDS NIH HHS R01 NS060887NINDS NIH HHS R01NS060887NINDS NIH HHS R01 NS063009NINDS NIH HHS R01NS063009NINDS NIH HHS R01 NS072441NINDS NIH HHS R01 NS31224-18NINDS NIH HHS R01-NS31224-18
6 · The paper itself

Abstract

There has been significant advancement in various aspects of scientific knowledge concerning the role of cerebellum in the etiopathogenesis of autism. In the current consensus paper, we will observe the diversity of opinions regarding the involvement of this important site in the pathology of autism. Recent emergent findings in literature related to cerebellar involvement in autism are discussed, including: cerebellar pathology, cerebellar imaging and symptom expression in autism, cerebellar genetics, cerebellar immune function, oxidative stress and mitochondrial dysfunction, GABAergic and glutamatergic systems, cholinergic, dopaminergic, serotonergic, and oxytocin-related changes in autism, motor control and cognitive deficits, cerebellar coordination of movements and cognition, gene-environment interactions, therapeutics in autism, and relevant animal models of autism. Points of consensus include presence of abnormal cerebellar anatomy, abnormal neurotransmitter systems, oxidative stress, cerebellar motor and cognitive deficits, and neuroinflammation in subjects with autism. Undefined areas or areas requiring further investigation include lack of treatment options for core symptoms of autism, vermal hypoplasia, and other vermal abnormalities as a consistent feature of autism, mechanisms underlying cerebellar contributions to cognition, and unknown mechanisms underlying neuroinflammation.

Indexed as

AnimalsAutistic DisorderCell Adhesion Molecules, NeuronalCerebellar DiseasesCerebellumCognition DisordersDisease Models, AnimalExtracellular Matrix Proteinsgamma-Aminobutyric AcidGene-Environment InteractionGlutamic AcidHumansMagnetic Resonance ImagingMitochondriaMovement DisordersNerve Tissue ProteinsCell Adhesion Molecules, NeuronalExtracellular Matrix Proteinsgamma-Aminobutyric AcidGlutamic AcidNerve Tissue ProteinsNeurotransmitter AgentsReelin ProteinSerine Endopeptidases

Identifiers

PMID22370873
PMCPMC3677555
OpenAlexW2020374060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.